Galapagos Company
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Founded Date:
1999-01-01
Funding Status:
IPO
Total Funding:
5446287155.0
Headquarters:
Mechelen-bovelingen, Limburg, Belgium
Last Funding Date:
2019-07-14
Investors Number:
6.0
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$100M to $500M
Industry:
Clinical Development